FCA
TMDX icon

FinTrust Capital Advisors’s Transmedics TMDX Stock Holding History

FinTrust Capital Advisors’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-300
Closed -$4 – 1145
2020
Q3 		$4 Buy
+300
New +$5.14K ﹤0.01% 994

Other funds holding TMDX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
SCP
Sandhill Capital Partners Buffalo, New York $1.16B AUM 12.37% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
KXA
KPCB XIII Associates Menlo Park, California $186M AUM 11.23% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

FinTrust Capital Advisors's TMDX Position: Q4 2020 in Review

FinTrust Capital Advisors sold out of Transmedics (TMDX) in Q4 2020, closing a stake of 300 shares — an estimated $4 sold.

FinTrust Capital Advisors first reported a position in TMDX in Q3 2020 and held it in 1 quarter. The position peaked at $4 in Q3 2020. 69 funds tracked by Wall St. Rank hold TMDX as of Q4 2020.

  • FinTrust Capital Advisors reported no remaining Transmedics position as of Q4 2020 after selling out during the quarter.
  • FinTrust Capital Advisors sold 300 Transmedics shares in Q4 2020, an estimated $4.
  • FinTrust Capital Advisors first reported a position in Transmedics in Q3 2020 and held it in 1 quarter.
  • FinTrust Capital Advisors's Transmedics position peaked at $4 in Q3 2020.
  • 69 funds tracked by Wall St. Rank held Transmedics as of Q4 2020.

Based on FinTrust Capital Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.